Maria Dobek, Vice President, Accounting at Janux Therapeutics, Inc. (JANX), sold 1,462 shares at $13.73 ($20K) on 2026-01-02, disclosed to the SEC on 2026-01-02.
Open-market sale of $20k JANX by Vice President, Accounting. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.